Add BrightSurf on Google Email

University of Alberta


Women are three times more likely than men to get severe long COVID: Here’s why

Research reveals key biological differences between women and men with long COVID, including elevated blood levels of intestinal fatty acid binding protein and reduced testosterone levels in affected women. These findings suggest potential targets for treatment that could bring relief to the 3.5 million Canadians affected.

SourceUniversity of Alberta·JournalCell Reports Medicine·TypeObservational study·DateNov 13, 2025

Endangered mountain caribou possess unique gut microbiome that may be important for recovery efforts

A new study from the University of Alberta found that endangered mountain caribou possess a unique gut microbiome in late winter, when they feed on tree lichens. This specialized diet and associated microbes could guide caribou recovery efforts and highlight the importance of maintaining oldgrowth forests to support their food supply.

SourceUniversity of Alberta·JournalMolecular Ecology·TypeExperimental study·DateJun 5, 2025

Damage to gut bacteria linked with chemo-induced weight gain in breast cancer patients

Researchers at the University of Alberta have discovered a correlation between chemotherapy-induced changes to gut bacteria and unhealthy weight gain in breast cancer patients. The study found that these patients gained abdominal fat and experienced inflammation, with significant changes to their gut microbiome.

SourceUniversity of Alberta·JournalBMC Medicine·TypeRandomized controlled/clinical trial·DateJul 11, 2023

Do forest trees really “talk” through underground fungi?

Researchers found no strong evidence that underground fungal networks, known as common mycorrhizal networks (CMNs), offer benefits to trees and their seedlings. While CMNs exist, there is limited understanding of their structure and function in the field, leading to questionable claims about resource transfer and seedling survival.

SourceUniversity of Alberta·JournalNature Ecology & Evolution·TypeLiterature review·DateFeb 13, 2023

World’s largest islet transplant program celebrates 20 years of changing lives for people with diabetes

The Edmonton Protocol team has reported that islet transplantation is an effective therapy for patients with difficult-to-control Type 1 diabetes, with a high rate of graft survival and insulin independence. The procedure has been shown to stabilize blood sugar levels and improve quality of life for patients.

SourceUniversity of Alberta·JournalThe Lancet Diabetes & Endocrinology·DateMay 19, 2022

Combination of drugs for obesity and Type 2 diabetes may be more effective than a single therapy

Canadian and German researchers have identified personalized prescriptions that combine drugs to treat obesity and Type 2 diabetes. The combination therapy shows higher effectiveness in some patients and fewer side effects compared to single drugs. Studies are now needed to understand why individuals respond differently to the treatment.

SourceUniversity of Alberta·JournalFrontiers in Endocrinology·DateMay 3, 2022

Hold the salt: Study reveals how reducing sodium intake can help patients with heart failure

A study of 806 patients with heart failure found that reducing sodium intake improved symptoms such as swelling, fatigue, and coughing. However, it had no effect on rates of death, hospitalization, or emergency department visits. The researchers recommend a lower sodium intake limit for heart failure patients.

SourceUniversity of Alberta·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateApr 2, 2022

Excess sugar consumption costs Canada’s health-care system $5 billion each year

A new study by University of Alberta researchers estimates that excessive sugar consumption in Canada results in $5 billion annual healthcare costs due to 16 chronic diseases. Limiting free sugar intake could reduce diabetes prevalence by 27% if Canadians follow the 10% recommendation, and 44.8% if they limit consumption to less than 5...

SourceUniversity of Alberta·JournalCanadian Journal of Public Health·DateMar 15, 2022

New 'cocktail' drug could benefit up to 45 per cent of patients with Duchenne muscular dystrophy

Researchers at the University of Alberta have developed a new cocktail of treatments that could benefit up to 45% of patients with Duchenne muscular dystrophy. The treatment uses an approach called 'exon skipping' to produce the protein needed to rebuild muscle tissue, addressing limitations of existing exon-skipping molecules.

SourceUniversity of Alberta·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateFeb 23, 2022